Vectors Research Management, LLC Processa Pharmaceuticals, Inc. Transaction History

Vectors Research Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.68 - $3.55 $6,720 - $14,200	4,000 New	4,000 $11,000
Q1 2022 May 16, 2022	SELL	$3.01 - $5.21 $12,040 - $20,840	-4,000 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$6.15 - $10.95 $24,600 - $43,800	4,000 New	4,000 $32,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vectors Research Management, LLC with notifications on news.